A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

ProMab has recently had our work published in JoVE on the real-time cytotoxicity assay (RTCA) that we use during our CAR-T cells research and development. Click to learn more!